Use to record summary or peristent information about the individual's pattern of use of harmful or hazardous use of (medications or other) legal and illegal substances.
Also known as substance abuse, and includes substance dependence, addiction and doping.
This archetype is to be used to record information about both current and previous substance use behaviour.
The specific scope of this archetype includes all types of addictive substances, including, but not limited to: recreational drugs; solvents; caffeine; amphetamines, barbiturates, benzodiazepines, cannabis, cocaine, hallucinogens, opioids, anabolic steroids, erythropoietin, or sniffing glue.
The only exceptions are alcohol consumption, tobacco smoking and smokeless tobacco use because these substances have been modelled in other, specific archetypes.
The 'Per type' cluster of data elements allows for recording of specific details and episodes about each type of substance used and can be repeated once per type.
The 'Episode' cluster allows for recording of specific details, routes and forms during a specified period of time. If the pattern, route or form changes significantly, record the details in a new instance of the Episode' CLUSTER.
Triggers for closing one episode and commencing a new one will largely reflect local data collection preferences, including if the individual:
- quits for a significant period of time; or
- significantly changes their amount, route or form of their substance use.
If multiple forms of the substance are consumed, the details will be recorded in the 'Per form' CLUSTER within this archetype.
If multiple routes are used, the details will be recorded in the 'Per route' CLUSTER within this archetype.
Use to incorporate the narrative descriptions of substance use habits within existing or legacy clinical systems into an archetyped format, using the 'Overall description' data element.
Organisation: Atomica Informatics
Email: heather.leslie@atomicainformatics.com
Date originally authored: 2020-02-13
Organisation: Atomica Informatics
Email: heather.leslie@atomicainformatics.com
Date originally authored: 2020-02-13
- Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
- Custodian Organisation: Ocean Informatics
- Current Contact: Heather Leslie, Atomica Informatics, heather.leslie@atomicainformatics.com
- Original Namespace: com.oceaninformatics
- Original Publisher: Ocean Informatics
- Custodian Namespace: com.oceaninformatics
- MD5-CAM-1.0.1: 7A611234611C608C4E402C7BD2758224
- Build Uid: 2957dfa5-3523-4c97-ac26-32c4f2e1f384
- Revision: 0.0.1-alpha
For example: local information requirements; or additional metadata to align with FHIR.
Include:
All not explicitly excluded archetypes
For example: 'stopped smoking substance for one day or longer with the intention of quitting'.
Definition may need to be specified per type.
Definition may need to be specified per type.
Definition may need to be specified per type. For example, the definition may not be zero, but less than a specified amount used during a specified time interval.
- Never used [The individual has never used the identified substance.]
- Current user [The individual is currently using the identified substance.]
- Former user [The individual has previously used the identified substance.]
Can be a partial date, for example, only a year.
Can be a partial date, for example, only a year. For example, this date could represent when the individual commenced using substances every Friday night or at parties.
Can be a partial date, for example, only a year.
Coding with an external terminology is preferred, where possible.
For example: A specific type could be 'marijuana' or 'hashish', while a group could be 'cannabis'. Or 'heroin', 'fentanyl', 'Vicodin' or 'morphine', while a group could be opioids. Coding with an external terminology is preferred, where possible.
- Current user [The individual is a current user of the specified type of substance.]
- Former user [The individual has previously used the specified substance, but is not a current user.]
- Never used [The individual has never used the specified type of substance.]
For example: '2' as the second episode within a sequence of episodes; or 'Pregnancy with twins' if describing the substance use during a health event such as a specific pregnancy.
Choice of:
Count
min: >=0
Text
Can be a partial date, for example, only a year.
Can be a partial date, for example, only a year. This data field will be empty if the episode is current and ongoing.
The typical pattern of use can be made more granular by coding with a terminology or a local value set in a template.
Choice of:
- Text
Coded Text- Daily [Use the substance at least once every day.]
- Non-daily [Not using the substance every day.]
Units:
- mg/d
- g/d
- mg/wk
- g/wk
- mg/mo
- g/mo
For example: the number of 'joints', 'user doses' or 'pills' per day or per week.
Units:
- >=0.0 1/d
Limit decimal places: 0 - >=0.0 1/wk
Limit decimal places: 0 - >=0.0 1/mo
Limit decimal places: 0
Units:
- 0.0..7.0 1/wk
- 0.0..31.0 1/mo
min: >=0
Include:
All not explicitly excluded archetypes
Runtime name constraint:
- Per form [Details about each form of the substance.
For example: buds or oil. ] - Per route [Details about each route of administration .
For example: intravenous or inhalation. ]
For example: 'smoking', 'nasal insufflation (sniffing and snorting)', 'injection', 'oil', 'powder', 'pills'.
Runtime name constraint:
- Form [The form of the substance administered.
] - Route [The route of administration of the substance.
]
Include:
All not explicitly excluded archetypes
Can be a partial date, for example, only a year. Definitions for a 'Quit date' vary enormously and can be defined using the 'Quit data definition' data element in the Protocol section of this archetype. This date will be identical to the 'Episode end date' for the most recent episode. This date could be used by decision support guidance to determine if the individual is at risk of relapse, for example in the first 12 months since quitting.
Include:
All not explicitly excluded archetypes
This data element does not take into account the amount of substanses used.
Silje Ljosland Bakke, Nasjonal IKT HF, Norway (openEHR Editor)
Heather Leslie, Atomica Informatics, Australia (openEHR Editor)
Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor)
John Tore Valand, Haukeland Universitetssjukehus, Norway (openEHR Editor)
Ingrid Skard, DIPS AS, Norway